A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Public ClinicalTrials.gov record NCT05709444. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease to Assess the Efficacy in Reducing Urinary Protein and Maintaining Podocyte Density and Function
Study identification
- NCT ID
- NCT05709444
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Palatin Technologies, Inc
- Industry
- Enrollment
- 16 participants
Conditions and interventions
Conditions
Interventions
- Bremelanotide Drug
- RAAS inhibition therapy Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 25, 2022
- Primary completion
- Apr 25, 2024
- Completion
- Apr 25, 2024
- Last update posted
- Oct 16, 2024
2022 – 2024
United States locations
- U.S. sites
- 9
- U.S. states
- 5
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Institute of Renal Research | Chula Vista | California | 91910 | — |
| California Institute of Renal Research DBA - Balboa Research | La Mesa | California | 91942 | — |
| Georgia Nephrology, LLC DBA -GA Nephrology Research Institute | Decatur | Georgia | 30030 | — |
| Georgia Nephrology, LLC [DBA] GA Nephrology Research Institute | Lawrenceville | Georgia | 30046 | — |
| Brookview Hills Research Associates, LLC | Winston-Salem | North Carolina | 27103 | — |
| Northeast Research Center, LLC | Bethlehem | Pennsylvania | 18017 | — |
| Nephrotex Research Group | Dallas | Texas | 75231 | — |
| Prolator Clinical Research Center | Houston | Texas | 77030 | — |
| Clinical Advancement Center, PLLC | San Antonio | Texas | 78212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05709444, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2024 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05709444 live on ClinicalTrials.gov.